General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-24 | 2024-03 | -0.27 | -0.26 | 0.01 | 3.70% |
2024-02-07 | 2023-12 | -0.25 | -0.25 | N/A | N/A |
2023-10-25 | 2023-09 | -0.22 | -0.23 | -0.01 | -4.55% |
2023-07-26 | 2023-06 | -0.21 | -0.19 | 0.02 | 9.52% |
2023-04-26 | 2023-03 | -0.24 | -0.25 | -0.01 | -4.17% |
2023-02-08 | 2022-12 | -0.23 | -0.26 | -0.03 | -13.04% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-01 | Truist Securities | Upgrade | Buy | Buy |
2023-08-07 | Stifel | Upgrade | Buy | |
2023-07-26 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-06-26 | Truist Securities | Upgrade | Buy | Buy |
2023-05-16 | Raymond James | Upgrade | Outperform | Outperform |
2023-05-15 | Oppenheimer | Upgrade | Outperform | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-05-01 | FOEHR MATTHEW W | Director | 111.25K | Purchase |
2024-03-26 | LIAN BRIAN | Chief Executive Officer | 2.27M | Stock Award(Grant) |
2020-08-25 | LIGAND PHARMACEUTICALS, INC. | Beneficial Owner of more than 10% of a Class of Security | 5.82M | Sale |
2023-05-15 | MACARTNEY LAWSON | Director | 47.97K | Sale |
2024-04-30 | MANCINI MARIANNA | Chief Operating Officer | 348.51K | Sale |
2019-01-02 | MASAMUNE HIROKO | Officer | 141.06K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | FMR, LLC | 14.98M | 242.76M | 14.97% |
2023-06-29 | Blackrock Inc. | 6.89M | 111.77M | 6.89% |
2023-06-29 | Vanguard Group Inc | 5.11M | 82.87M | 5.11% |
2023-06-29 | State Street Corporation | 4.82M | 78.12M | 4.82% |
2023-06-29 | Viking Global Investors, L.P. | 3.54M | 57.46M | 3.54% |
2023-06-29 | Alliancebernstein L.P. | 2.96M | 48.01M | 2.96% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | Fidelity Growth Company Fund | 3.31M | 45.76M | 3.31% |
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.88M | 39.83M | 2.88% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.70M | 43.84M | 2.70% |
2023-08-30 | iShares Russell 2000 ETF | 2.20M | 30.34M | 2.20% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.26M | 20.45M | 1.26% |
2023-07-30 | American Century Heritage Fund | 1.19M | 17.33M | 1.19% |
Is that a BULL Flag Let’s Go ApexTradez @ IG or X deep dive and long haul HOLD
$VKTX 2 years away from any revenue. Only
Phase 2. Game will evolve before then.
Why is everyone always saying a buyout is coming. Like why ???
Over 90 NO Way. Yall be smoking some good shit
IV flush for options traders bastards
Who said there is supposed to be ti be an announcement today ?
When is the data ? If you don’t know don’t post bullshit dates
Guys look at the chart. This is forming a possible inverse head n shoulders. Be patient
Sell the news event. Taking profits everytime we pop
Chart is setting up for a perfect inverse head and shoulders baby. Let’s fucking explode
Learn technicals. The chart is showing you it’s going down today. Stop hopium
Should dump into close
Should be a down day tomorrow. We got a possible inverse head n shoulders on the daily possibly forming
This could be a sell the news. Just saying
That’s weird news by LLY
Don’t like the news just posted. Call flow for nvo and LLY. Put pkay for VKTX you do you I’m out
When are we suppose to have data ?
You know da rulez!!!
It’s interesting to read ppl say pump and dump. I mean I get it, but reports say it’s better than Eli Lilly’s drug which counts for something. The problem is it’s only in phase 2. I’m sure they will be bought out the only question is when